MAHON PAUL A
SEC CIK 1231589 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | EVP, GC | 53.5K | — | $246.06M | 232 | 2021-07-01 | 2026-09-17 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $844.54M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 232
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-03-04 | 2022-01-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2022-02-18 | 2022-02-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $202.17 | -6,000 | 35.5K | -14% | -$1.21M |
| D | 2022-02-18 | 2022-02-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 36.4K | +20% | +$666.0K |
| DM | 2022-02-04 | 2022-02-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $200.10 | -6,000 | 30.4K | -16% | -$1.20M |
| D | 2022-02-04 | 2022-02-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 36.4K | +20% | +$666.0K |
| DM | 2022-01-21 | 2022-01-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $205.57 | -6,000 | 32.1K | -16% | -$1.23M |
| DM | 2022-01-21 | 2022-01-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 36.4K | +20% | +$666.0K |
| DM | 2022-01-06 | 2022-01-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale | $192.46 | -6,000 | 33.1K | -15% | -$1.15M |
| DM | 2021-12-17 | 2021-12-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $195.53 | -6,000 | 42.0K | -13% | -$1.17M |
| D | 2021-12-17 | 2021-12-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-12-02 | 2021-12-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $189.36 | -6,000 | 40.0K | -13% | -$1.14M |
| D | 2021-12-02 | 2021-12-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-11-18 | 2021-11-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $199.33 | -6,000 | 42.2K | -12% | -$1.20M |
| D | 2021-11-18 | 2021-11-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| D | 2021-11-04 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-11-04 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $201.19 | -6,000 | 36.4K | -14% | -$1.21M |
| DM | 2021-10-21 | 2021-10-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $190.18 | -6,000 | 36.4K | -14% | -$1.14M |
| D | 2021-10-21 | 2021-10-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-10-07 | 2021-10-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $190.52 | -6,000 | 37.2K | -14% | -$1.14M |
| D | 2021-10-07 | 2021-10-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-09-16 | 2021-09-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $204.08 | -6,000 | 36.4K | -14% | -$1.22M |
| D | 2021-09-16 | 2021-09-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-09-02 | 2021-09-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $210.94 | -6,000 | 36.4K | -14% | -$1.27M |
| D | 2021-09-02 | 2021-09-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| D | 2021-08-24 | 2021-08-23 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $111.00 | +6,000 | 42.4K | +16% | +$666.0K |
| DM | 2021-08-24 | 2021-08-23 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $205.82 | -6,000 | 36.5K | -14% | -$1.23M |
| D | 2021-08-06 | 2021-08-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $94.96 | +5,500 | 41.9K | +15% | +$522.3K |
| D | 2021-08-06 | 2021-08-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $205.42 | -5,500 | 36.4K | -13% | -$1.13M |
| D | 2021-07-16 | 2021-07-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $94.96 | +6,000 | 42.4K | +16% | +$569.8K |
| D | 2021-07-16 | 2021-07-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $184.19 | -6,000 | 36.4K | -14% | -$1.11M |
| D | 2021-07-02 | 2021-07-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $184.67 | -6,000 | 36.4K | -14% | -$1.11M |
| D | 2021-07-02 | 2021-07-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $94.96 | +6,000 | 42.4K | +16% | +$569.8K |
Purchase Sale Sale after option exercise All abbreviations